ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for alerts Register for real-time alerts, custom portfolio, and market movers
Mangoceuticals Inc

Mangoceuticals Inc (MGRX)

0.275
-0.0074
( -2.62% )
Updated: 14:14:10

Unlock more advanced trading tools

Join ADVFN today

Key stats and details

Current Price
0.275
Bid
0.2653
Ask
0.275
Volume
19,152
0.2627 Day's Range 0.289999
0.143 52 Week Range 2.38
Market Cap
Previous Close
0.2824
Open
0.27
Last Trade
1000
@
0.275
Last Trade Time
13:54:22
Financial Volume
$ 5,354
VWAP
0.279533
Average Volume (3m)
862,619
Shares Outstanding
17,039,500
Dividend Yield
-
PE Ratio
-0.50
Earnings Per Share (EPS)
-0.54
Revenue
731k
Net Profit
-9.21M

About Mangoceuticals Inc

Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was i... Mangoceuticals, Inc. focuses on develops, markets, and sells various men's wellness products and services through a telemedicine platform. It offers erectile dysfunction products under the Mango brand name. The company sells its products through online website mangorx.com. Mangoceuticals, Inc. was incorporated in 2021 and is headquartered in Dallas, Texas. Mangoceuticals, Inc. operates as a subsidiary of Cohen Enterprises, Inc. Show more

Sector
Health & Allied Services,nec
Industry
Health & Allied Services,nec
Website
Headquarters
Dallas, Texas, USA
Founded
1970
Mangoceuticals Inc is listed in the Health & Allied Services sector of the NASDAQ with ticker MGRX. The last closing price for Mangoceuticals was $0.28. Over the last year, Mangoceuticals shares have traded in a share price range of $ 0.143 to $ 2.38.

Mangoceuticals currently has 17,039,500 shares outstanding. The market capitalization of Mangoceuticals is $4.60 million. Mangoceuticals has a price to earnings ratio (PE ratio) of -0.50.

MGRX Latest News

Mangoceuticals Subsidiary, MangoRx Mexico, Executes Technical Agreement with Mexican Pharmaceutical Manufacturer for Initial Development and Production of its Mango Erectile Dysfunction (ED) Products

Signifies the first major step towards the application process for the certification of its Mango ED oral dissolvable products by Mexico’s health governing agency, COFEPRIS Dallas, Texas, April...

MangoRx Officially Launches ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Treatment

The Dallas Based, Direct-to-Consumer Telemedicine Company Brings the FDA-Approved Oral Testosterone Replacement Therapy Treatment to the Telehealth Market Dallas, Texas, March 12, 2024 (GLOBE...

MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

Newly developed clinic prescribing system will allow Doctors to prescribe MangoRx products from within practices and clinics Dallas, Texas, Feb. 20, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals...

MANGORX AWARDS SAN FRANCISCO TEAM FREE MANGORX ED PRODUCTS FOR ONE YEAR FOLLOWING BIG GAME LOSS TO KANSAS CITY

San Francisco Fans Nationwide Get Three Free Mangorx ED Pills Based on Sunday’s Game Point Difference Dallas, Texas, Feb. 13, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX...

MANGORX TO OFFER THE BIG GAME’S LOSING TEAM A FREE ONE YEAR SUPPLY OF ITS ED PRODUCT, MANGO, TO HELP RAISE… SPIRITS

MangoRx Wants to Keep Fumbles on the Field, Not in the Bedroom, Offering the Losing Team Free MangoRx ED Products for One Year Dallas, Texas, Feb. 06, 2024 (GLOBE NEWSWIRE) -- Mangoceuticals...

MangoRx Accepting Pre Orders for its “PRIME”, by MangoRx, Powered by Kyzatrex®️ FDA Approved Oral Testosterone Replacement Therapy (TRT) Product

The Dallas Based, Direct-to-Consumer Telemedicine Company to Offer 2 Months of Free ‘PRIME’ by MangoRx, Powered by Kyzatrex®️ (a $498 value) for First 1,000 Subscribers Dallas, Texas, Feb. 05...

MangoRx’s Brand and Products to be Featured by Barstool Sports in Week of Programming Around the Biggest Sports Event of the Year on February 11

"King of the Internet" Dave Portnoy's Uber-Popular Sports Media Company to Spotlight FDA-Approved Oral Testosterone Replacement ‘Prime’ by MangoRx, Powered by Kyzatrex®  Dallas, Texas, Jan. 19...

Mangoceuticals, Inc. Announces Pricing of $1,200,000 Public Offering

Dallas, Texas, Dec. 15, 2023 (GLOBE NEWSWIRE) -- Mangoceuticals, Inc. (Nasdaq: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s...

MANGOCEUTICALS TO INTRODUCE “PRIME”, POWERED BY KYZATREX®️ (CIII TESTOSTERONE UNDECANOATE CAPSULES), FOR AN FDA APPROVED ORAL TESTOSTERONE REPLACEMENT THERAPY (TRT) PRODUCT

The Dallas Based, Direct-to-Consumer Telemedicine Company Secures Marketing Agreement with Marius Pharmaceuticals Bringing KYZATREX to the Telehealth Market as ‘Prime’ by MangoRx Dallas, Texas...

Mangoceuticals Launches MangoRx Mexico Subsidiary, Paving the Way for Over-the-Counter Retail of Erectile Dysfunction Line of Products in Latin America

Tapping into a market of more than 40,000 pharmacies, retail outlets, and convenience stores across Mexico in 2024 and fueling International Sales Access Across Latin America Dallas, Texas, Dec...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.01626.259659969090.25880.30990.25091437180.28989576CS
40.076238.32997987930.19880.30990.19012376050.25340796CS
12-0.101-26.86170212770.3760.4861450.1438626190.2600012CS
26-0.6545-70.41420118340.92950.990.1437640610.35909323CS
52-1.175-81.03448275861.452.380.1437644380.9956241CS
156-3.925-93.45238095244.24.26940.14310995341.17241472CS
260-3.925-93.45238095244.24.26940.14310995341.17241472CS

Market Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.325
(113.39%)
175.63M
AIREreAlpha Tech Corporation
$ 1.04
(72.19%)
21.34M
AMSTAmesite Inc
$ 3.27
(63.50%)
66.23M
BOFBranchOut Food Inc
$ 1.87
(59.83%)
101.05M
LICNLichen China Limited
$ 0.85
(51.79%)
13.38M
NCINeo Concept International Group Holdings Ltd
$ 2.5477
(-73.18%)
4.41M
ISUNiSun Inc
$ 0.0908
(-39.06%)
8.01M
GCTKGlucoTrack Inc
$ 0.4783
(-37.07%)
1.42M
ATXIAvenue Therapeutics Inc
$ 0.0913
(-31.87%)
9.85M
EVOEvotec SE
$ 5.2399
(-31.50%)
1.33M
CSSEChicken Soup for the Soul Entertainment Inc
$ 0.325
(113.39%)
175.63M
TSLATesla Inc
$ 161.22
(11.43%)
147.15M
SQQQProShares UltraPro Short QQQ
$ 11.8394
(-0.59%)
109.84M
BOFBranchOut Food Inc
$ 1.87
(59.83%)
101.05M
AMSTAmesite Inc
$ 3.27
(63.50%)
66.23M

MGRX Discussion

View Posts
koolmc koolmc 2 weeks ago
nice bounce back after hitting .15's low in march
👍️0
krisc62 krisc62 1 month ago
Lol! What a clown!
👍️0
Invest-in-America Invest-in-America 1 month ago
MGRX: This circus sideshow carnival routine could still NOT get its PRICE 'UP' --- no sexual innuendo intended --- even if DONALD TRUMP had just tried their stuff & made World News Tonight by proclaiming that he got his first 'HARD-ON' since his last date with 'STORMY DANIELS' over 4-years ago!!!
👍️0
Monksdream Monksdream 1 month ago
Wash trade bot this morning
👍️0
6of1 6of1 1 month ago
the super bowl lie
👍️0
NorfolkIP NorfolkIP 2 months ago
What specifically makes it a “scam”?
👍️0
6of1 6of1 2 months ago
i guess by now you know its a scam
👍️0
FUNYMUNY FUNYMUNY 2 months ago
What a shit show this is
👍️0
BeachBum BeachBum 2 months ago
https://www.otcmarkets.com/filing/html?id=17286151&guid=nrd-kpJOCvxHJth

purposes:

1. To approve an Amendment to the Company’s Certificate of Formation, as amended to approve a reverse stock split of the Company’s outstanding common stock. Stockholders are being asked to approve an amendment to our Certificate of Formation, as amended, to effect a reverse stock split of our issued and outstanding shares of our common stock, par value $0.0001 per share, by a ratio of between one-for-two to one-for-fifty inclusive, with the exact ratio to be set at a whole number to be determined by our Board of Directors or a duly authorized committee thereof in its discretion, at any time after approval of the amendment and prior to [_________], 2025 (the “Reverse Split Proposal”).
👍️0
FUNYMUNY FUNYMUNY 2 months ago
I'll pray you find your way...for now, you get the ignore button.
👍️0
Backstabbed Backstabbed 2 months ago
$MGRX - NEWS OUT! MangoRx Launches Direct-To-Clinics Sales Division to Drive and Fuel Customer Acquisition and Revenue Growth

February 20 2024 - 09:00AM

Alert
Print
Share On Facebook

Mangoceuticals, Inc. (NASDAQ: MGRX) (“MangoRx” or the “Company”), a company focused on developing, marketing, and selling a variety of men’s health and wellness products via a secure telemedicine platform, including its uniquely formulated erectile dysfunction (ED) drug (‘Mango’), its hair growth product (‘GROW’), and its FDA approved oral testosterone replacement therapy (TRT), ‘PRIME’, by MangoRx, powered by Kyzatrex®️, is excited to announce that it has officially launched its direct-to-clinics sales division offering doctors and medical practitioners the ability to prescribe MangoRx products to their patients directly from their offices, clinics and brick and mortar locations. The Company also reports that it has successfully onboarded its first medical health and wellness clinic based in Dallas, TX last week.
The Company believes that this direct-to-clinics initiative will assist in fueling a greater amount of recurring revenues while at the same time reducing customer acquisition costs (CACs) associated with traditional digital marketing strategies. The first of its kind within MangoRx’s direct competitor group, the Company will be deploying a boots-on-the-ground sales force with a mission to penetrate existing brick and mortar men’s health and wellness clinics across the United States, including but not limited to Med Spas, Low Testosterone clinics, and specialty doctors’ offices.

Jonathan Arango, MangoRx’s Co-Founder and President noted, “we are very excited for the launch of this direct-to-clinics initiative as this has been a part of our business plan and in the works since the 4th quarter of 2023. Since we have launched our Mango ED products, many doctors have approached us asking how they could prescribe Mango to their existing patients. This led us to design our newly custom-built prescribing system that allows for the practitioner to prescribe MangoRx products – including our newly launched ‘PRIME’, by MangoRx, powered by Kyzatrex®️ – while at the same time acquiring a new MangoRx customer within our ecosystem.”

MangoRx transactions are currently being initiated by consumers seeking MangoRx’s products. This newly developed prescribing system will now allow for prescribing doctors and medical practitioners to initiate the transaction for the sale of MangoRx’s products. The Company will be activating a website where providers and clinics can visit to complete the onboarding process to qualify as a MangoRx preferred provider.

Jacob Cohen, MangoRx’s Co-Founder and CEO noted, “our initial research has shown that some of these providers prescribe as many as 6,000 to 7,000 ED prescriptions per year from within their offices or clinics. This amount, compounded with the opportunity for them to also prescribe ‘PRIME’, by MangoRx, powered by Kyzatrex®️, presents an exponential growth opportunity especially given PRIME’s $199 monthly subscription rate. We are confident that this new initiative will fuel our revenue growth and have a further impact on making MangoRx a household name.”

About MangoRx

MangoRx is focused on developing a variety of men's health and wellness products and services via a secure telemedicine platform. To date, the Company has identified men's wellness telemedicine services and products as a growing sector and especially related to the area of erectile dysfunction (ED), hair growth and hormone replacement therapies. Interested consumers can use MangoRx’s telemedicine platform for a smooth experience. Prescription requests will be reviewed by a physician and, if approved, fulfilled and discreetly shipped through MangoRx’s partner compounding pharmacy and right to the patient’s doorstep.

To learn more about MangoRx’s mission and other products, please visit www.MangoRx.com or on social media @Mango.Rx.
👍️0
power11 power11 2 months ago
JOUKOUKOU22 WHERE ARE YOU ?? ARE YOU COUNTING YOUR PROFITS YET ??
👍️0
power11 power11 2 months ago
JOUKOUKOU....HOW ARE YOU ?? HOLDING STRONG HERE ???
👍️0
power11 power11 2 months ago
ARE YOU GONNA RELOAD AT 10 CENTS OR LOWER ??
👍️0
Backstabbed Backstabbed 2 months ago
Still holding here from $0.35 braw…
👍️0
Golden Cross Golden Cross 2 months ago
mmmmm
👍️0
power11 power11 2 months ago
HOW CAN I TRADE WITHOUT YOUR PUMP RECOMMENDATION ??
HOW ABOUT ANOTHER RECOMMENDATION ?? GIVE YOU ANOTHER SHOT AT IT
👍️0
Carjockey2 Carjockey2 2 months ago
You keep posting I'll keep making money..

IGPK

CGAC

DLOC
👍️0
Carjockey2 Carjockey2 2 months ago
Jesus man trade something and make some money will you.... instead of worrying about me..

Having a particularly nice week myself how about you??


LMMFAO

Clearly you're obsessed 90% of your posts are to me and I'm not even paying attention to you but somebody told me you were posting to me..

👍️0
power11 power11 2 months ago
HOW ABOUT A NEW CODE NAME : TRUCKJOUKOUKOU SINCE THE CAR AIN'T WORKING !!
WHAT DO YOU THINK ?? YOU NEED TO RESTART THE PUMP !!
👍️0
power11 power11 2 months ago
JOUKOUKOU...WHERE ARE YOU HIDING THIS MORNIG, MGRX NEEDS YOUR SUPPORT GIRL !!
YOU KNOW THE SUPERBOWL THING DID NOT WORK OUT LAST TIME IN THE PUMPING OPERATION;
I HAVE ANOTHER IDEA FOR YOU : WHY DON'T YOU TRY THE UPCOMING MARCH MADNESS CHAMPIONSHIP !!
HOW ABOUT THAT ?? NEVER KNOW......GIVE IT A SHOT !!
👍️0
power11 power11 2 months ago
JOUKOUKOU....WHERE ARE YOU !!
MGRX NEEDS SOME PUMPING THIS MORNING, MORONS ARE WAITING FOR YOU !!
GO AT IT GIRL !! DON'T BE SHY !!
👍️0
power11 power11 2 months ago
YOU NEED TO ASK THE NO.ONE PUMPER HERE MISS CARJOUKOUKOU TO KEEP PUMPING !!
SHE'S GOOD AT IT !!
👍️0
Backstabbed Backstabbed 2 months ago
$MGRX - holding up well here. Setting up for that pop to close gap. IMO
👍️0
power11 power11 2 months ago
ONE DESCRIBE ONLY THEMSELVES !! GOT IT SENIORITA PITA !! I THINK YOU NEED A MARGERITTA !!
👍️0
power11 power11 2 months ago
OK THEN; YOU'RE ONE OF THOSE PUMPERS !! KEEP PUMPING.....NEXT STOP 10 PENNIES.
👍️0
FUNYMUNY FUNYMUNY 2 months ago
Might look into decaf
👍️0
crowin crowin 2 months ago
Does MGRX have a Muffler Bearing issue too!
👍️0
power11 power11 2 months ago
THERE IS NO GOOD NEWS COMING BUDDY; WHAT WE HAVE ON THIS BOARD
IS A BUNCH OF PUMPERS, SAME PERSON WITH DIFFERENT ALIASES POSTING
CREATING THE IMPRESSION OF MANY INDIVIDUALS .
👍️0
Carjockey2 Carjockey2 2 months ago
16th post to me..LMAO

Some are just children masquerading as adults..

👍️0
Backstabbed Backstabbed 2 months ago
$MGRX - any good news and this goes.
👍️0
power11 power11 2 months ago
WOW...AND I MEAN WOW....HOW QUICKLY WE CHANGE OUR TUNE !!
PUMP AND PUMP AND NOW THAT YOU SOLD INTO THE PUMP......SUDDENLY THIS
COMPANY CAN'T GET IT'S ACT TOGETHER. AMAZING...SIMPLY AMAZING HOW THICK IS YOUR BULLSHIT.
👍️0
BeachBum BeachBum 2 months ago
I don’t short stocks. That PR today reminded me of how the CEO operates. I was giving him another chance after what he did to his last ticker. You’ll understand soon enough imo.
👍️0
pumpnass pumpnass 2 months ago
No matter what I don’t trust Jacob 1 bit. He’s your typical penny stock CEO in a Nasdaq shell
👍️0
Backstabbed Backstabbed 2 months ago
Yes it was closed based on an 8K released by the company.

The underwriters had a warrant to purchase shares and they did and probably were sold. Who knows
👍️0
pumpnass pumpnass 2 months ago
They did a filing for an S1 to raise money. They never said they raised enough money and stated that the S1 was officially closed now did they? So obviously it’s still going on so you have investors using it as an ATM until then
👍️0
Backstabbed Backstabbed 2 months ago
Why was this never an issue before you jumped in prior to the superbowl weekend?

Now it’s all of a sudden an issue?

Are you short on this stock?
👍️0
Backstabbed Backstabbed 2 months ago
They already did an offering not long ago. So where does this dilution talk come from

It’s getting pushed down and manipulated no doubt
👍️0
BeachBum BeachBum 2 months ago
OTC shows 17 mil around Oct which is about 14 times IPO. Not sure what the O/S is now but can’t be the same imo. The IPO was a $5 mil market cap and the market cap now is about the same if not lower guessing there are now more than 17 mil outstanding. MGRX needs $1.00 or they will eventually have to reverse split. How will MGRX get the market cap to $20 mil+ avoiding a reverse split? Just numbers.
👍️0
pumpnass pumpnass 2 months ago
The company is printing shares at a record pace because they have no money
👍️0
BeachBum BeachBum 2 months ago
How many more shares outstanding now compared to IPO day? 1.25 mil at $4.00, wasn’t it? Blaming shorts for the drop is a bit much imo.
👍️0
BeachBum BeachBum 2 months ago
I judge him for name dropping the 49ers in a PR to drive share price. It’s cute I guess. Good luck with that.
👍️0
Backstabbed Backstabbed 2 months ago
And you are judging him for trying to get exposure?
👍️0
BeachBum BeachBum 2 months ago
Using the SF 49ers name to drive share price is a bit much considering there’s no relationship between Mango and the losing team. It’s like a public birth control med company sending an unsolicited freebie to a female mega star, expecting they will promote or even use the product shortly after. The PR was stupid and the market agreed. Cohen looks desperate to get to $1.00+.
👍️0
Backstabbed Backstabbed 2 months ago
I thought it was humorous and funny. But I guess retail gave a golden opportunity and helped offshore hedge funds to cover at these ridiculous low prices.

👍️0
BeachBum BeachBum 2 months ago
Today’s PR didn’t help. Cohen clearly has nothing to PR so he put out that rubbish hoping to attract new traders. Anyone who thinks a pro football player is going to order free dick meds from Mango is delusional.
👍️0
BeachBum BeachBum 2 months ago
So many promising PR’s all the way to .0001 with AMIH, Cohens last ticker. AMIH shareholders got screwed over there. I expect the same here. No way he gets MGRX into compliance after the last week of trading.
👍️0
Carjockey2 Carjockey2 2 months ago
1000% correct

Agreed this company could never get it together. They had so many chances and dropped the ball every time. Just a bunch of smoke and mirrors here. If the Jacob would focus 1% on building a real company instead of the 100% he focuses on his swag he could have something here. Who the heck is gonna pay the prices he charges when the major companies he’s trying to compete with are 1/10th the price. Just my 2 cents
👍️0
pumpnass pumpnass 2 months ago
I know the company and the CEO. It’s facts. Jacob has a huge ego he needs to come back down to earth and listen to his investors and people he puts around him.
👍️0
Backstabbed Backstabbed 2 months ago
Company is trying hard to promote itself and to attract new patients. Big companies that produce Viagra are in control of the bigger market.

It’s unfair to judge a CEO by the PPS cause it is mainly manipulation and naked short selling by offshore hedge funds.

I also expected the stock to fly on Super Bowl promo with barstool, but the real results won’t come till later this month
👍️0

Your Recent History

Delayed Upgrade Clock